217 related articles for article (PubMed ID: 21951195)
1. Effect of surfactants on the characteristics of fluconazole niosomes for enhanced cutaneous delivery.
Gupta M; Vaidya B; Mishra N; Vyas SP
Artif Cells Blood Substit Immobil Biotechnol; 2011 Dec; 39(6):376-84. PubMed ID: 21951195
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis.
Gupta M; Goyal AK; Paliwal SR; Paliwal R; Mishra N; Vaidya B; Dube D; Jain SK; Vyas SP
J Liposome Res; 2010 Dec; 20(4):341-50. PubMed ID: 20163329
[TBL] [Abstract][Full Text] [Related]
3. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
Balakrishnan P; Shanmugam S; Lee WS; Lee WM; Kim JO; Oh DH; Kim DD; Kim JS; Yoo BK; Choi HG; Woo JS; Yong CS
Int J Pharm; 2009 Jul; 377(1-2):1-8. PubMed ID: 19394413
[TBL] [Abstract][Full Text] [Related]
4. Sorbitan ester niosomes for topical delivery of rofecoxib.
Das MK; Palei NN
Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid.
Junyaprasert VB; Singhsa P; Suksiriworapong J; Chantasart D
Int J Pharm; 2012 Feb; 423(2):303-11. PubMed ID: 22155414
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of follicular delivery of finasteride by liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models.
Tabbakhian M; Tavakoli N; Jaafari MR; Daneshamouz S
Int J Pharm; 2006 Oct; 323(1-2):1-10. PubMed ID: 16837150
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery.
Paolino D; Muzzalupo R; Ricciardi A; Celia C; Picci N; Fresta M
Biomed Microdevices; 2007 Aug; 9(4):421-33. PubMed ID: 17252206
[TBL] [Abstract][Full Text] [Related]
8. Applying the Taguchi method to optimize sumatriptan succinate niosomes as drug carriers for skin delivery.
González-Rodríguez ML; Mouram I; Cózar-Bernal MJ; Villasmil S; Rabasco AM
J Pharm Sci; 2012 Oct; 101(10):3845-63. PubMed ID: 22806266
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of oleic acid vesicles for the topical delivery of fluconazole.
Zakir F; Vaidya B; Goyal AK; Malik B; Vyas SP
Drug Deliv; 2010 May; 17(4):238-48. PubMed ID: 20235758
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery.
Alsarra IA
J Microencapsul; 2009 May; 26(3):272-8. PubMed ID: 18720197
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis.
Alvi IA; Madan J; Kaushik D; Sardana S; Pandey RS; Ali A
Anticancer Drugs; 2011 Sep; 22(8):774-82. PubMed ID: 21799471
[TBL] [Abstract][Full Text] [Related]
12. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin.
Pardakhty A; Varshosaz J; Rouholamini A
Int J Pharm; 2007 Jan; 328(2):130-41. PubMed ID: 16997517
[TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus.
Bendas ER; Abdullah H; El-Komy MH; Kassem MA
Int J Pharm; 2013 Dec; 458(2):287-95. PubMed ID: 24184035
[TBL] [Abstract][Full Text] [Related]
14. Transdermal enhancement through rat skin of luciferase plasmid DNA loaded in elastic nanovesicles.
Manosroi A; Khositsuntiwong N; Götz F; Werner RG; Manosroi J
J Liposome Res; 2009; 19(2):91-8. PubMed ID: 19241277
[TBL] [Abstract][Full Text] [Related]
15. Niosomes vs microemulsions: new carriers for topical delivery of Capsaicin.
Tavano L; Alfano P; Muzzalupo R; de Cindio B
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):333-9. PubMed ID: 21684725
[TBL] [Abstract][Full Text] [Related]
16. An electron spin resonance study of non-ionic surfactant vesicles (niosomes).
Yeom S; Shin BS; Han S
Chem Phys Lipids; 2014 Jul; 181():83-9. PubMed ID: 24721595
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
Bhatia A; Kumar R; Katare OP
J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
[TBL] [Abstract][Full Text] [Related]
18. Optimization of methotrexate loaded niosomes by Box-Behnken design: an understanding of solvent effect and formulation variability.
Zidan AS; Mokhtar Ibrahim M; Megrab NAE
Drug Dev Ind Pharm; 2017 Sep; 43(9):1450-1459. PubMed ID: 28420295
[TBL] [Abstract][Full Text] [Related]
19. A new approach for the evaluation of niosomes as effective transdermal drug delivery systems.
Muzzalupo R; Tavano L; Cassano R; Trombino S; Ferrarelli T; Picci N
Eur J Pharm Biopharm; 2011 Sep; 79(1):28-35. PubMed ID: 21303691
[TBL] [Abstract][Full Text] [Related]
20. Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin.
Manconi M; Sinico C; Valenti D; Lai F; Fadda AM
Int J Pharm; 2006 Mar; 311(1-2):11-9. PubMed ID: 16439071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
